Clinical effects observation of levocarnitine combined with sucrose iron injection for treatment of maintenance hemodialysis patients with renal anemia
10.3760/cma.j.issn.1008-6315.2015.10.018
- VernacularTitle:左卡尼汀联合蔗糖铁注射液治疗维持性血液透析患者肾性贫血的临床效果观察
- Author:
Weihua YAO
- Publication Type:Journal Article
- Keywords:
Levocarnitine;
Sucrose iron injection;
Renal anemia
- From:
Clinical Medicine of China
2015;31(10):925-927
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical effects of levocarnitine combined with sucrose iron injection for treatment of maintenance hemodialysis patients with renal anemia.Methods Forty-four cases of patients with maintenance hemodialysis merged renal anemia were randomly divided into control group (n =22) and treatment group(n=22).All patients were administrated conventional therapy.The sucrose iron injection was administrated with control group at hemodialysis, while treatment group administrated levocamitine after hemodialysis on this basis.The hemoglobin (Hb) and erythrocyte specific volume (Hct) were compared after treatment for 8 weeks,and the clinical effects were evaluated.Results After treatment for 8 weeks, the Hb and Hct(treatment group: (105.69±11.94) g/L, (0.31±0.04);control group: (86.31±11.39) g/L,0.27±0.05) had increased significantly compared with prior treatment(treatment group:(62.65± 12.74) g/L, (0.19±0.04;control group: (63.33 ± 13.23) g/L, 0.20± 0.06) in two groups, and the treatment group increased more significant than control group accompanied with significant statistically difference (t =3.197,2.978;P ＜0.05).Also,the total effective rate of treatment group was 86.4％(19/22) ,which higher than control group(50.0％ (11/22)) accompanied with significant statistically difference (x2 =6.705, P＜0.05).Conclusion The therapy of levocarnitine combined with sucrose iron injection can obviously improve anemia symptoms in patients with maintenance hemodialysis and worthy of popularization and application.
